Coverage
-
August 13, 2021
Boston Scientific Corp. on Thursday prevailed in a False Claims Act suit accusing the company of selling defective defibrillators, with a Minnesota federal judge ruling that the case hasn't turned up any evidence that would convince a reasonable jury to find the company intentionally misrepresented its devices to regulators.
4 other articles on this case.
View all »